{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:35:58Z","timestamp":1740116158014,"version":"3.37.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","brainanddevelopment.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.braindev.2024.07.004","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T21:35:39Z","timestamp":1723584939000},"page":"320-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term observation of patients with advanced late-onset Pompe disease undergoing enzyme replacement therapy: A 15-year observation in a single center"],"prefix":"10.1016","volume":"46","author":[{"given":"Madoka","family":"Mori-Yoshimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hotake","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Unuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Yorimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakana","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2024.07.004_bb0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3389","article-title":"Glycogen storage disease type II; acid alpha-glycosidase (acid maltase) deficiency","author":"Hirshhorn","year":"2001"},{"key":"10.1016\/j.braindev.2024.07.004_bb0010","series-title":"Myology","first-page":"1559","article-title":"Acid maltase deficiency","author":"Engel","year":"2004"},{"issue":"21","key":"10.1016\/j.braindev.2024.07.004_bb0015","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.3390\/jcm10214828","article-title":"A systematic review and Meta-analysis of enzyme replacement therapy in late-onset Pompe disease","volume":"10","author":"Dornelles","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.braindev.2024.07.004_bb0020","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2024.07.004_bb0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","article-title":"Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis","volume":"264","author":"Schoser","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2024.07.004_bb0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00415-021-10526-5","article-title":"Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis","volume":"269","author":"Sarah","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2024.07.004_bb0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nmd.2022.01.001","article-title":"Long-term effects of enzyme replacement therapy in an elderly cohort of late-onset Pompe disease","volume":"32","author":"Winkler","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2024.07.004_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10545-011-9393-6","article-title":"Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study","volume":"35","author":"Furusawa","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2024.07.004_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ncn3.66","article-title":"Late-onset Pompe disease after 4 years of enzyme replacement therapy: an autopsy case","volume":"1","author":"Furusawa","year":"2014","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.braindev.2024.07.004_bb0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JND-220792","article-title":"Diagnostic yield of Chilaiditi\u2019s sign in advanced-phase late-onset Pompe disease","volume":"9","author":"Takahashi","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.braindev.2024.07.004_bb0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease","volume":"149","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.braindev.2024.07.004_bb0060","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/jcsm.12555","article-title":"Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles","volume":"11","author":"Nu\u00f1ez-Peralta","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.braindev.2024.07.004_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ymgme.2017.06.007","article-title":"Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme\u00ae) in 12 patients with advanced late-onset Pompe disease","volume":"122","author":"Papadopoulos","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2024.07.004_bb0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.braindev.2012.01.013","article-title":"Quantitative computed tomography for enzyme replacement therapy in Pompe disease","volume":"34","author":"Yonee","year":"2012","journal-title":"Brain and Development"},{"key":"10.1016\/j.braindev.2024.07.004_bb0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/jimd.12272","article-title":"Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: prospective analysis from the French Pompe registry","volume":"43","author":"Semplicini","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2024.07.004_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.nmd.2020.12.001","article-title":"Effect of long term enzyme replacement therapy in late onset Pompe disease: a single-Centre experience","volume":"31","author":"Papadimas","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2024.07.004_bb0085","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease: a 5-year prospective study","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.braindev.2024.07.004_bb0090","doi-asserted-by":"crossref","first-page":"e1756","DOI":"10.1212\/WNL.0000000000008441","article-title":"Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease","volume":"93","author":"Harlaar","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.07.004_bb0095","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1007\/s00415-021-10409-9","article-title":"STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa","volume":"268","author":"Gutschmidt","year":"2021","journal-title":"J Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:27:53Z","timestamp":1730464073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760424000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0387760424000998"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2024.07.004","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term observation of patients with advanced late-onset Pompe disease undergoing enzyme replacement therapy: A 15-year observation in a single center","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2024.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}